Literature DB >> 15831684

Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: a population based cohort study.

Siobhan Hickling1, Joseph Hung, Matthew Knuiman, Konrad Jamrozik, Brendan McQuillan, John Beilby, Peter Thompson.   

Abstract

STUDY
OBJECTIVE: To investigate the effect of the voluntary folate fortification policy in Australia on serum folate and total plasma homocysteine (tHcy) concentrations.
DESIGN: Population based cohort study.
SETTING: Perth, Western Australia. PARTICIPANTS: Men and women aged 27 to 77 years (n = 468), who were originally randomly selected from the Perth electoral roll. The cohort was surveyed in 1995/96 before widespread introduction of folate fortification of a variety of foods, and followed up on two occasions, firstly in 1998/99 and again in 2001, when a moderate number of folate fortified foods were available. Subjects with abnormal serum creatinine concentrations at baseline were excluded from this analysis. MAIN
RESULTS: Repeated measures analysis of variance was used to determine changes in serum folate and tHcy over the three surveys and to assess whether time trends were related to age, sex, MTHFR C677T genotype, or consumption of folate fortified foods. An increase (38%) in mean serum folate (p < 0.0005) and a decrease (21%) in mean tHcy (p < 0.0005) were seen after introduction of the voluntary folate fortification policy in Australia. Serum folate was consistently higher (p = 0.032) and tHcy was consistently lower (p = 0.001) in subjects who consumed at least one folate fortified food compared with subjects who did not consume any folate fortified foods in the previous week. The time related changes in serum folate and tHcy were affected only by intake of folate fortified foods (p < 0.0005) and not by any other measured variables including age, sex, or MTHFR genotype.
CONCLUSION: Voluntary fortification of foods with folate in Australia has been followed by a substantial increase in serum folate and decrease in tHcy in the general population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831684      PMCID: PMC1733078          DOI: 10.1136/jech.2004.027078

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  15 in total

1.  Dietary strategies for lowering homocysteine concentrations.

Authors:  L J Riddell; A Chisholm; S Williams; J I Mann
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

2.  Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies.

Authors:  Leonelo E Bautista; Iván A Arenas; Anderson Peñuela; Luz X Martínez
Journal:  J Clin Epidemiol       Date:  2002-09       Impact factor: 6.437

3.  The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B-12 deficiency in elderly people.

Authors:  Sandra Hirsch; Pía de la Maza; Gladys Barrera; Vivian Gattás; Margarita Petermann; Daniel Bunout
Journal:  J Nutr       Date:  2002-02       Impact factor: 4.798

4.  Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection.

Authors:  A Araki; Y Sako
Journal:  J Chromatogr       Date:  1987-11-27

5.  A computerised dietary analysis system for use with diet diaries or food frequency questionnaires.

Authors:  K I Baghurst; S J Record
Journal:  Community Health Stud       Date:  1984

6.  Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study.

Authors:  Floor V A van Oort; Alida Melse-Boonstra; Ingeborg A Brouwer; Robert Clarke; Clive E West; Martijn B Katan; Petra Verhoef
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

7.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23

8.  Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)

Authors:  B M McQuillan; J P Beilby; M Nidorf; P L Thompson; J Hung
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

9.  Trends in neural tube defects in Western Australia.

Authors:  Carol Bower; Aandra Ryan; Edwina Rudy; Margaret Miller
Journal:  Aust N Z J Public Health       Date:  2002-04       Impact factor: 2.939

10.  Declining rate of folate insufficiency among adults following increased folic acid food fortification in Canada.

Authors:  J G Ray; M J Vermeulen; S C Boss; D E C Cole
Journal:  Can J Public Health       Date:  2002 Jul-Aug
View more
  3 in total

Review 1.  Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity.

Authors:  Simon Gilbody; Tracy Lightfoot; Trevor Sheldon
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

2.  The impact of MTHFR 677 C/T genotypes on folate status markers: a meta-analysis of folic acid intervention studies.

Authors:  Natalie J Colson; Helen L Naug; Elham Nikbakht; Ping Zhang; Joanna McCormack
Journal:  Eur J Nutr       Date:  2015-10-23       Impact factor: 5.614

Review 3.  Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis.

Authors:  Boyi Yang; Shujun Fan; Xueyuan Zhi; Yinuo Wang; Yanxun Wang; Quanmei Zheng; Guifan Sun
Journal:  Nutrients       Date:  2014-12-29       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.